Nektar Therapeutics (NKTR)

Nektar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	30.11	35.28	88.23	25.22	198.96	96.36
Short-Term Investments	214.39	268.34	416.75	708.74	862.94	1,228
Cash & Short-Term Investments	244.5	303.62	504.98	733.96	1,062	1,325
Cash Growth	-34.39%	-39.88%	-31.20%	-30.88%	-19.85%	-0.79%
Accounts Receivable	-	1.21	5.98	22.49	38.89	36.8
Other Receivables	2.12	1.05	2.42	1.4	5.1	6.5
Receivables	2.12	2.25	8.4	23.89	43.99	43.3
Inventory	-	16.1	19.2	15.8	15.29	12.67
Prepaid Expenses	2.85	4.41	5.99	-	-	-
Other Current Assets	37.01	4.33	7.4	21.93	16.83	40.72
Total Current Assets	286.48	330.7	545.97	795.58	1,138	1,422
Property, Plant & Equipment	12.43	36.86	85.89	177.54	186.14	199.84
Long-Term Investments	4.54	25.83	-	64.83	136.66	279.12
Goodwill	-	-	76.5	76.5	76.5	76.5
Other Long-Term Assets	4.52	4.64	2.25	2.74	1.46	0.34
Total Assets	307.97	398.03	710.6	1,117	1,539	1,977
Accounts Payable	8.58	9.85	12.98	9.75	22.14	19.23
Accrued Expenses	29.23	16.46	28.85	58.01	79.73	63.74
Current Portion of Long-Term Debt	-	-	-	-	-	252.89
Current Portion of Leases	21.5	19.26	18.67	17.44	13.92	12.52
Current Unearned Revenue	-	-	-	-	-	5.52
Other Current Liabilities	8.28	5.7	7.71	-	-	-
Total Current Liabilities	67.58	51.27	68.2	85.2	115.78	353.89
Long-Term Debt	97.83	112.63	155.38	195.43	200.34	72.02
Long-Term Leases	86.76	98.52	112.83	125.74	136.37	142.73
Long-Term Unearned Revenue	-	-	-	-	-	2.55
Other Long-Term Liabilities	6.91	4.64	7.55	31.32	8.98	0.77
Total Liabilities	259.08	267.05	343.96	437.68	461.47	571.97
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	3,655	3,608	3,575	3,517	3,389	3,271
Retained Earnings	-3,603	-3,477	-3,201	-2,833	-2,309	-1,865
Comprehensive Income & Other	0.36	0.08	-6.91	-4.16	-2.3	-1.01
Shareholders' Equity	48.88	130.99	366.64	679.51	1,077	1,405
Total Liabilities & Equity	307.97	398.03	710.6	1,117	1,539	1,977
Total Debt	206.09	230.4	286.87	338.6	350.63	480.16
Net Cash (Debt)	42.94	99.04	218.1	460.18	847.93	1,124
Net Cash Growth	-66.39%	-54.59%	-52.60%	-45.73%	-24.55%	-29.25%
Net Cash Per Share	0.21	0.52	1.17	2.51	4.75	6.42
Filing Date Shares Outstanding	184.46	183.62	189.24	186.27	182.18	177.56
Total Common Shares Outstanding	184.46	191.38	188.56	185.47	180.09	176.51
Working Capital	218.9	279.43	477.76	710.38	1,022	1,068
Book Value Per Share	0.27	0.68	1.94	3.66	5.98	7.96
Tangible Book Value	48.88	130.99	290.14	603.01	1,001	1,329
Tangible Book Value Per Share	0.27	0.68	1.54	3.25	5.56	7.53
Buildings	3.83	43.18	74.89	97.39	92.98	93.1
Machinery	15.29	61.83	79.76	104	100.47	95.23
Construction In Progress	0.14	0.74	2.53	7.16	4.7	5.22

Source: S&P Capital IQ. Standard template. Financial Sources.